Phuong N. Huynh

Array ( [id] => 6745067 [patent_doc_number] => 20030022250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Functional IgE test methods and compositions' [patent_app_type] => new [patent_app_number] => 10/158568 [patent_app_country] => US [patent_app_date] => 2002-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7135 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022250.pdf [firstpage_image] =>[orig_patent_app_number] => 10158568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6801204 [patent_doc_number] => 20030096369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Non-anaphylactogenic IgE vaccines' [patent_app_type] => new [patent_app_number] => 10/152190 [patent_app_country] => US [patent_app_date] => 2002-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 18323 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20030096369.pdf [firstpage_image] =>[orig_patent_app_number] => 10152190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6710501 [patent_doc_number] => 20030170250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Local delivery of long lasting therapeutic agents' [patent_app_type] => new [patent_app_number] => 10/152232 [patent_app_country] => US [patent_app_date] => 2002-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15051 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170250.pdf [firstpage_image] =>[orig_patent_app_number] => 10152232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 693884 [patent_doc_number] => 07070780 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-04 [patent_title] => 'Treatment of demyelinating autoimmune disease with ordered peptides' [patent_app_type] => utility [patent_app_number] => 10/152654 [patent_app_country] => US [patent_app_date] => 2002-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5102 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/070/07070780.pdf [firstpage_image] =>[orig_patent_app_number] => 10152654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6736002 [patent_doc_number] => 20030013637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Novel anti-autoimmune composition by inhibition of GRF action' [patent_app_type] => new [patent_app_number] => 10/147087 [patent_app_country] => US [patent_app_date] => 2002-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17156 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013637.pdf [firstpage_image] =>[orig_patent_app_number] => 10147087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847371 [patent_doc_number] => 20030166538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Novel gene' [patent_app_type] => new [patent_app_number] => 10/134345 [patent_app_country] => US [patent_app_date] => 2002-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8739 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166538.pdf [firstpage_image] =>[orig_patent_app_number] => 10134345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6735488 [patent_doc_number] => 20030013123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Methods of isolating trophoblast cells from maternal blood' [patent_app_type] => new [patent_app_number] => 10/128848 [patent_app_country] => US [patent_app_date] => 2002-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6235 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013123.pdf [firstpage_image] =>[orig_patent_app_number] => 10128848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711037 [patent_doc_number] => 20030170786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Vascular endothelial growth factor 2' [patent_app_type] => new [patent_app_number] => 10/120398 [patent_app_country] => US [patent_app_date] => 2002-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 100341 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 244 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170786.pdf [firstpage_image] =>[orig_patent_app_number] => 10120398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6796401 [patent_doc_number] => 20030175274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Vascular endothelial growth factor 2' [patent_app_type] => new [patent_app_number] => 10/120414 [patent_app_country] => US [patent_app_date] => 2002-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 102010 [patent_no_of_claims] => 133 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175274.pdf [firstpage_image] =>[orig_patent_app_number] => 10120414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 930943 [patent_doc_number] => 06979447 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-27 [patent_title] => 'Immunomodulation and effect on cell processes relating to serotonin family receptors' [patent_app_type] => utility [patent_app_number] => 10/112261 [patent_app_country] => US [patent_app_date] => 2002-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 51 [patent_no_of_words] => 44695 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/979/06979447.pdf [firstpage_image] =>[orig_patent_app_number] => 10112261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6838456 [patent_doc_number] => 20030035796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'Novel compound for treatment of allergy and asthma' [patent_app_type] => new [patent_app_number] => 10/108301 [patent_app_country] => US [patent_app_date] => 2002-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5581 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20030035796.pdf [firstpage_image] =>[orig_patent_app_number] => 10108301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1133467 [patent_doc_number] => 06783959 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-31 [patent_title] => 'Methods and compositions relating to CD39-like polypeptides and nucleic acids' [patent_app_type] => B1 [patent_app_number] => 10/107576 [patent_app_country] => US [patent_app_date] => 2002-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 48 [patent_no_of_words] => 44089 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/783/06783959.pdf [firstpage_image] =>[orig_patent_app_number] => 10107576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1139786 [patent_doc_number] => 06780977 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-24 [patent_title] => 'Methods and compositions relating to CD39-like polypeptides and nucleic acids' [patent_app_type] => B1 [patent_app_number] => 10/107660 [patent_app_country] => US [patent_app_date] => 2002-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 48 [patent_no_of_words] => 44074 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/780/06780977.pdf [firstpage_image] =>[orig_patent_app_number] => 10107660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1009115 [patent_doc_number] => 06899875 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-31 [patent_title] => 'Methods and compositions relating to CD39-like polypeptides and nucleic acids' [patent_app_type] => utility [patent_app_number] => 10/108171 [patent_app_country] => US [patent_app_date] => 2002-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 48 [patent_no_of_words] => 33796 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/899/06899875.pdf [firstpage_image] =>[orig_patent_app_number] => 10108171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6673821 [patent_doc_number] => 20030059424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics' [patent_app_type] => new [patent_app_number] => 10/103686 [patent_app_country] => US [patent_app_date] => 2002-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 22204 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20030059424.pdf [firstpage_image] =>[orig_patent_app_number] => 10103686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6648159 [patent_doc_number] => 20030104532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Soluble inhibitors of vascular endothelial growth factor and use thereof' [patent_app_type] => new [patent_app_number] => 10/104610 [patent_app_country] => US [patent_app_date] => 2002-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 17609 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20030104532.pdf [firstpage_image] =>[orig_patent_app_number] => 10104610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048616 [patent_doc_number] => 20020169125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Recombinant production of polyanionic polymers and uses thereof' [patent_app_type] => new [patent_app_number] => 10/101487 [patent_app_country] => US [patent_app_date] => 2002-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15146 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20020169125.pdf [firstpage_image] =>[orig_patent_app_number] => 10101487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1192784 [patent_doc_number] => 06730489 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-04 [patent_title] => 'Antibodies to truncated VEGF-D and uses thereof' [patent_app_type] => B1 [patent_app_number] => 10/100037 [patent_app_country] => US [patent_app_date] => 2002-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 8782 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/730/06730489.pdf [firstpage_image] =>[orig_patent_app_number] => 10100037 [rel_patent_id] =>[rel_patent_doc_number] =>)